High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)
Original languageEnglish
JournalCancer Research
Publication statusPublished - 27 Aug 2020

Cite this